Skip to content

Clinical trials

Phase 2 Dermatitis trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatitis Phase: Phase 2 Country / region: Canada Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20183
20191
20233
20242
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated4
Active, not recruiting3
Recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Apollo Therapeutics Ltd2
GlaxoSmithKline2
Inmagene LLC2
Novartis Pharmaceuticals2
AbbVie1
Aclaris Therapeutics, Inc.1
Amgen1
Incyte Corporation1
McMaster University1
Q32 Bio Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatitis15
Dermatitis, Atopic12
Eczema12
Skin Diseases8
Immune System Diseases5
Acne Vulgaris1
Alopecia1
Alopecia Areata1
Genetic Diseases, Inborn1
Hidradenitis1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.